
ADVIA Centaur XP Immunoassay SystemHow does your lab meet varied testing demands?
Can your lab handle both routine and specialized testing without sacrificing efficiency? Can you maintain speed and accuracy for an increasingly diverse patient population? The high-performance ADVIA Centaur® XP system has more onboard reagents and dedicated STAT capabilities to maximize productivity, regardless of volume or types of tests. Always ready, continuous operation without interruption.
- High throughput, up to 240 tests/hour
- Intuitive software for ease of operation
- STAT port guarantees priority sampling at any time
- Data archive reduces administrative tasks
- Extensive menu with 30 onboard reagents
- Increase productivity by connecting to Siemens' Aptio™ Automation, ADVIA® Automation, StreamLAB® Automation or VersaCell® Solutions
Features & Benefits
Comprehensive Menu
- Comprehensive diagnostic testing covers screening, diagnosis, risk assessment and monitoring
- 30 onboard reagents maximize test capacity
Powerful Productivity
- High throughput, up to 240 tests per hour, to keep pace with peak workload times
- High-resolution touch screen for easy interaction
- Expanded ancillary reagent and fluid capacity
- Data archive feature reduces time for administrative tasks
- Universal sample rack design eliminates manual tasks
Excellent Patient Care
- STAT port guarantees priority sampling at any time
- Disposable pipette tips eliminate sample-to-sample carryover
- Automatic dilution, repeat and reflex testing
- Smart Algorithm Software automatically repeats and confirms reactive testing
Superior Service
- 360º status light displays system information visible from all points
- User interface adjusts for customized ergonomics
- No daily startup with automated maintenance features
- New instrument sensors enhance remote diagnostic functions
Flexible Solutions
- Connectivity to Aptio™ Automation, ADVIA® Automation, StreamLAB® Automation and VersaCell® Solutions
- Siemens Remote Service (SRS) proactively maintains Siemens' systems
Assays
Anemia
Active B12
EPO
Ferritin
Folate
RBC Folate
Vitamin B12
Autoimmune
Anti-CCP IgG
Bone Metabolism
Intact PTH
Vitamin D Total
Cardiac
BNP
CKMB
High-Sensitivity Troponin I
Myoglobin
NT-proBNP
Diabetes
C-Peptide
Insulin
Hepatitis
Anti-HBe
Anti-HBs 2
HAV IgM
HAV Total
HBc IgM
HBc Total
HBc Total 2
HBeAg
HBsAg Confirmatory
HBsAg II
HBsAg II Quant
HCV
HIV
HIV 1/0/2 Enhanced (EHIV)
HIV Ag/Ab Combo (CHIV)
Immunosuppressant Drugs
Cyclosporine
Everolimus*
Sirolimus*
Tacrolimus*
Inflammation
IgE Total
IL-6
LBP
TNFα*
Liver Fibrosis
Enhanced Liver Fibrosis (ELF™) Test
HA (ELF™ Marker)
PIIINP (ELF™ Marker)
TIMP-1 (ELF™ Marker)
Metabolic
Cortisol
Homocysteine
Neurology
β-Amyloid 1-42 (AB42)*
Total Tau (TTAU)*
Oncology
AFP
BR 27.29
CA 125II†
CA 15-3†
CA 19-9†
Calcitonin
CEA
Complexed PSA
CYFRA 21-1*
Free PSA
Neuron Specific Enolase (NSE)*
PSA
Serum HER-2/neu
Squamous Cell Carcinoma Antigen (SCC)*
Reproductive Endocrinology
AFP
Androstenedione
Anti-Müllerian Hormone*
DHEA-SO4
Enhanced Estradiol
Free Beta HCG
FSH
hCG
LH
PAPP-A
PIGF*
Progesterone
Prolactin
sFLT-1*
SHBG
Testosterone II
Sepsis
Procalcitonin (PCT)
Special ID
EBV-EBNA IgG*
EBV-VCA IgG*
EBV-VCA IgM*
SARS-CoV-2 Ag (CoVAg)**
SARS-CoV-2 IgG (COV2G)§
SARS-CoV-2 IgG (sCOVG)**
SARS-CoV-2 Total (COV2T)§
Syphilis
Zika Test‡
Therapeutic Drug Monitoring
Carbamazepine
Digitoxin
Digoxin
Gentamicin
Phenobarbital
Phenytoin
Theophylline
Valproic Acid
Vancomycin
Thyroid
aTgII
Anti-TPO
Free T3
Free T4
Total T3
Total T4
TSH3-Ultra
TSH
T Uptake
ToRCH
CMV IgG
CMV IgM*
Herpes-1 IgG
Herpes-2 IgG
Rubella IgG II
Rubella IgM
Toxoplasma IgG
Toxoplasma IgM
Technical Specifications
Pomohli vám tieto informácie?
* Under development. Not available for sale.
† CA 125II , CA 19-9 and CA 15-3 are trademarks of Fujirebio Diagnostics, Inc.
‡ Limited distribution.
§ This test has not been FDA cleared or approved. This test has been authorizedby FDA under an EUA for use by authorized laboratories. This test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary by country.
** This test has not been reviewed by the FDA. In the US, use of this test is limited to laboratories that are certified under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. Product availability may vary by country and is subject to regulatory requirements.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.